Terazosin is a medication used in the management and treatment of benign prostatic hyperplasia and essential hypertension. Terazosin is a long-acting, selective alpha-1 adrenergic receptor antagonist. This activity reviews the indications, action, and contraindications for Terazosin as a valuable agent in managing benign prostatic hyperplasia, essential hypertension, and nephrolithiasis.

**Objectives:**
- Describe the pharmacokinetics and pharmacodynamics of terazosin with emphasis on the context of patient safety.
- Identify the indications for terazosin therapy.
- Review the mechanism of action of terazosin that leads to its therapeutic effect.
- Summarize interprofessional team strategies regarding the appropriate uses of terazosin to enhance patient safety and comfort while minimizing the risk of adverse events.